Subscribe Log in

Log in

Remember me. [?]
Forgotten password
Not got an account?

Subscribe or register here

Toggle navigation
Student BMJ
Search
  • News & views
    • At a glance >>
    • Life
    • Briefings
    • Research explained
    • Views
    • People
  • Clinical
    • Practical skills
    • Clinical reviews
    • Ethics & law
    • Picture quizzes
    • Junior doctor survival kit
  • Specialties
    • Cardiology
    • Emergency medicine
    • Gastroenterology
    • General practice
    • General Surgery
    • Geriatric medicine
    • Neurology
    • Obstetrics & Gynaecology
    • Paediatrics
    • Psychiatry
    • Radiology
    • Respiratory
  • Careers
    • Career planning
    • A career in...
    • Electives
    • Foundation programme
    • Careers advice
  • Applying to medical school
    • At a glance >>
    • Application timeline
    • Considering medicine
    • Medical School Selector
    • Work experience
    • Personal statement
    • Entrance exams
    • Interviews
    • Plan B
    • Graduate entry medicine
    • Mediprep course
  • Subscribe

Cost of AIDS drug slashed in Brazil

By: Jonas Souza

The Swiss pharmaceutical giant Hoffman-La Roche has agreed to reduce the price of its AIDS drug, Viracept, by 40% after pressure from the Brazilian government. The agreement comes after the government said that it would declare AIDS a “national emergency,” triggering a law that would allow domestic production of cheaper, generic versions of drugs when the government judges that a manufacturer's prices are unobtainable.

Viracept, known generically as nelfinavir, is one of about a dozen drugs that make up the drug cocktail that patients with AIDS take to try to control the disease. Its price would fall from US$1.07 (26p) to 64 cents a pill, saving Brazil $35.4m a year. The $88mspenton nelfinavir every year accounts for 29% of Brazil's $303m anti-AIDS budget and the annual number of deaths from AIDS has fallen from 11 024 to 4136 in four years.

If Brazil had carried out its threat to ignore

To read the rest of this article log in or subscribe to Student BMJ.

If you're not ready to subscribe yet you can access News & views for free or register with us to receive free updates on our latest content.

Log in Subscribe
  • Most viewed
  • What's new

Stay in touch

  • Register for email alerts

Contact us

  • Contact us
  • Advertisers and sponsors
  • Media

About Student BMJ

  • About us
  • Join the BMA
  • Subscribe
  • Write for Student BMJ
  • Review articles for Student BMJ
  • The BMJ
  • The Student BMJ scholarship
  • Request permissions
  • Sitemap

Terms and Conditions

  • Website T&Cs
  • Medical School Selector T&Cs
  • Privacy policy

© BMJ Publishing Group Limited 2018. All rights reserved.